KAABEV Trademark

Trademark Overview


On Tuesday, February 25, 2020, a trademark application was filed for KAABEV with the United States Patent and Trademark Office. The USPTO has given the KAABEV trademark a serial number of 88810003. The federal status of this trademark filing is REGISTERED as of Tuesday, March 16, 2021. This trademark is owned by Glaxo Group Limited. The KAABEV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
kaabev

General Information


Serial Number88810003
Word MarkKAABEV
Filing DateTuesday, February 25, 2020
Status700 - REGISTERED
Status DateTuesday, March 16, 2021
Registration Number6292214
Registration DateTuesday, March 16, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 29, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 28, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 16, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, December 29, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 29, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 9, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 23, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 22, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 22, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 22, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 22, 2020NON-FINAL ACTION E-MAILED
Wednesday, April 22, 2020NON-FINAL ACTION WRITTEN
Tuesday, March 3, 2020ASSIGNED TO EXAMINER
Friday, February 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 28, 2020NEW APPLICATION ENTERED IN TRAM